Service delivery
What has been implemented and delivered: assessments, diagnostics, facilities and workforce training.
HeartLINK+ evaluates the complete cardiovascular-care pathway—from first access and diagnostic quality to interpretation, referral completion and follow-up.
What has been implemented and delivered: assessments, diagnostics, facilities and workforce training.
How reliably the pathway functions: quality, turnaround, completion and patient drop-off.
Performance in datasets or analyses supported by HeartLINK+; distinct from independent evaluation.
External academic or scientific assessment through prospectively designed studies and independent analysis.
Service volume demonstrates delivery experience. It does not, by itself, establish improved patient outcomes or independent clinical effectiveness.
Source: Cumulative program activity in Ghana reported by HeartLINK+, through 30 August 2026. A patient may receive more than one diagnostic service; these totals are not unique patient counts or independently validated patient outcomes.
Delivery and diagnostic experienceCardiovascular assessments and diagnostics delivered across facilities, frontline workforce training, internal triage validation and high test completion among people who reached the hub.
Independent external validation, prospective clinical utility, improved referral completion, long-term engagement, cost-effectiveness and cardiovascular outcomes.
Service activity, study context and the measures needed to understand clinical utility.
Explore deliveryWhat has been tested internally, and the questions remaining for independent evaluation.
Explore validationWhere patients leave the pathway, and how implementation learning can change delivery.
Explore implementation learningCompleted services, workforce training and operating experience.
H-TRIAGE™ performance, diagnostic yield and implementation learning.
Appropriate evaluation, management change, completion and closure.
External academic analysis and prospectively designed studies.
Performance across populations, facility types and health systems.
Treatment, risk-factor control, clinical events and sustained engagement.
This is the evaluation pathway, not a claim that every stage has been completed.
| Program | Research focus |
|---|---|
| LISTEN | AI-enabled auscultation, cardiovascular findings and triage |
| INSIGHT | Workforce-enabled echocardiography, quality and learning curves |
| I-HEART | Prospective evaluation of appropriate testing and linkage within 14 days |
| VALIDATE | Cross-country performance and generalizability |
| PRIME-CM | Pharmacy-based access, CKM assessment and hub-model comparison |
HeartLINK+ research areas, summarized in September 2026. Study protocols, current status and public records can be requested from the research team; the listing does not imply completed studies or published findings.
Ask for the study methods, reporting period, analysis cohort or available scientific materials behind a specific claim.
Name the result or research area you want to examine. You do not need to submit a research proposal to request information.
Clinical implementation, diagnostics, operational performance and quality improvement.
Research coordination, equitable-access programs and evidence generation.
Study design, independent analysis, scientific interpretation and dissemination.
Research agreements define data control, access, analysis, publication, authorship and intellectual-property protections.
Discuss the methods and evaluation questions that could strengthen the pathway.